-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Azacitidine + Cedazuridine) in Refractory Anemia With Ringed Sideroblasts
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Azacitidine + Cedazuridine) in Refractory Anemia With Ringed Sideroblasts Drug Details: ASTX-030, a fixed dose...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cadonilimab in Signet Ring Cell Squamous Cell Carcinoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Cadonilimab in Signet Ring Cell Squamous Cell Carcinoma Drug Details: Cardinalizumab (Ketanil) is a bi-specific...
-
Product Insights
Pannonia Ring
Pannonia Ring is an Onshore Wind project located in Vas, Hungary. The project is owned by Pannonia Szel Kft. and is developed by ImWind Group GmbH; Windpower Hungaria Kft.. The project is currently partially active. Empower your strategies with our Pannonia Ring report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain...
-
Product Insights
Maestrale Ring Wind Farm
Maestrale Ring Wind Farm is an Onshore Wind project located in Vojvodina, Serbia. The project is owned and being developed by Fintel Energija ad Beograd. The project is at the permitting stage. Empower your strategies with our Maestrale Ring Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections...
-
Company Insights
Innovation and Patenting activity of TEIKOKU PISTON RING CO., LTD. Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of TEIKOKU PISTON RING CO., LTD. Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report...
-
Product Insights
Jiaxing ECD – Jiaxing Urban Expressway: Ring Road Phase III Stage II – Zhejiang
Equip yourself with the essential tools needed to make informed and profitable decisions with our Jiaxing ECD – Jiaxing Urban Expressway: Ring Road Phase III Stage II – Zhejiang report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Acquire...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Iodine I 131 Apamistamab in Refractory Anemia With Ringed Sideroblasts
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Iodine I 131 Apamistamab in Refractory Anemia With Ringed Sideroblasts Drug Details:Iomab-B, a radioimmunoconjugate (BC8-I-131 construct)...
-
Product Insights
NewReproductive Health Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Reproductive Health Devices Pipeline Market Report Overview Endometrial ablation devices, female sterilization devices, reversible contraceptive devices, and assisted reproductive technology devices are the main categories of reproductive health devices. The reproductive health devices pipeline report provides comprehensive information about the main products with their comparative segment-wise analysis at various stages of development. The report also covers the regional and country-wise reproductive health devices clinical trials outlook. The regulatory paths followed for conducting the reproductive health devices pipeline research are also...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Azacitidine + Cedazuridine) in Refractory Anemia With Excess Blasts
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Azacitidine + Cedazuridine) in Refractory Anemia With Excess Blasts Drug Details: ASTX-030, a fixed dose...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Azacitidine + Cedazuridine) in Chronic Myelomonocytic Leukemia (CMML)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Azacitidine + Cedazuridine) in Chronic Myelomonocytic Leukemia (CMML) Drug Details: ASTX-030, a fixed dose combination...